InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（6 笔）
内部人交易记录
董事已披露买入
3
已披露卖出
6
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by De Backer Marianne, 董事. Officer active across 3 companies, notably Kronos Bio, Inc.. In total, 19 disclosures have been published. Breakdown: 3 buys · 6 sells. Total volume traded: €2.3m. Activity tracked since 28 May 2021. The latest transaction was filed on 29 April 2026 (J). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to De Backer Marianne
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
233,532 股0Common StockSEC:0001628280-26-029041:1
233,532 股0Common StockSEC:0001628280-26-029041:0
72,559 股@ US$9.15635.1% 占其流量Common StockSEC:0001628280-26-024098:0
14,762 股@ US$9.53266.8% 占其流量Common StockSEC:0001628280-26-012390:0
285,000 股0Common StockSEC:0001628280-26-011327:0
79,712 股@ US$5.949440.3% 占其流量Common StockSEC:0001628280-25-016800:0
240,000 股0Common StockSEC:0001628280-25-007693:0
53,118 股0Common StockSEC:0001628280-24-027797:0
72,995 股@ US$9.457759.7% 占其流量Common StockSEC:0001628280-24-014878:0
175,000 股0Common StockSEC:0001628280-24-006984:0
576,452 股0Common StockSEC:0001209191-23-022777:0
7,867 股0Common StockSEC:0001209191-23-003081:0
11,333 股0Common StockSEC:0001209191-22-039788:0
6,400 股0Common StockSEC:0001209191-22-002586:0
2,244 股@ US$64.2525.2% 占其流量Common StockSEC:0001209191-22-001323:0
1,150 股@ US$11.5736.2% 占其流量Common StockSEC:0001209191-21-067658:0
标准退出：2022年3月1日 (T+90)
500 股@ US$19.5025.8% 占其流量Common StockSEC:0001209191-21-053243:0
标准退出：2021年11月18日 (T+90)
5,000 股@ US$89.8574.8% 占其流量Common StockSEC:0001209191-21-043406:0
600 股@ US$25.0138.0% 占其流量Common StockSEC:0001209191-21-036799:0
标准退出：2021年8月26日 (T+90)
19 条申报中的 19 条
About De Backer Marianne
De Backer Marianne is an Administrateur. She is associated with Vir Biotechnology, Inc. as President and CEO, with Arrowhead Pharmaceuticals, INC. as Director, and with Kronos Bio, Inc. as Director. She has made 19 filings in total, and across the 19 sampled filings, the stated buy and sell amounts are 32400 and 2264660, with a range from 2021-06-01 to 2026-04-30. The most frequent transaction nature is Attribution.
